Pirfenidone use in fibrotic diseases: What do we know so far?
- DOI
- 10.1002/iid3.1335
- Published
- 2024 Jul
- Container
- Immunity, inflammation and disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/iid3.1335,
title = {Pirfenidone use in fibrotic diseases: What do we know so far?},
author = {Torre A and Martínez-Sánchez FD and Narvaez-Chávez SM and Herrera-Islas MA and Aguilar-Salinas CA and Córdova-Gallardo J},
year = {2024},
journal = {Immunity, inflammation and disease},
doi = {10.1002/iid3.1335},
url = {https://doi.org/10.1002/iid3.1335}
}RIS
TY - JOUR TI - Pirfenidone use in fibrotic diseases: What do we know so far? AU - Torre A AU - Martínez-Sánchez FD AU - Narvaez-Chávez SM AU - Herrera-Islas MA AU - Aguilar-Salinas CA AU - Córdova-Gallardo J PY - 2024 JO - Immunity, inflammation and disease DO - 10.1002/iid3.1335 UR - https://doi.org/10.1002/iid3.1335 ER -
APA
A, T., FD, M., SM, N., MA, H., CA, A., & J, C. (2024). Pirfenidone use in fibrotic diseases: What do we know so far?. Immunity, inflammation and disease. https://doi.org/10.1002/iid3.1335
Source records
- pubmed · retrieved 2026-09-24T20:40:42.513Z
- europe-pmc · retrieved 2026-09-24T20:40:42.535Z
- doaj · retrieved 2026-09-24T20:40:42.553Z